Experience With the Once-Yearly Histrelin (GnRHa) Subcutaneous Implant in the Treatment of Central Precocious Puberty

Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s3298
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search